SOURCE: Med Spas of America Inc.

June 10, 2008 16:40 ET

Essential Ingredient in Natural Renu Chosen "Best for Skin Refining"

ATLANTA, GA--(Marketwire - June 10, 2008) - Med Spas of America Inc. (PINKSHEETS: MEDP),, announced today that Dr. Jon Bragi Bjaranson's age management marine enzyme called Penzim, the main ingredient in its Natural Renu anti-aging cream, was chosen in the March 2008 issue of Psychologies as best for skin refining.

A survey of 200 readers of Psychologies, a U.K. women's magazine, conducted a trial of 100 anti-aging creams selected from categories across the market, is one of the first to blind-test every product involved. Anti-aging products, such as Ponds, Lancome and Skinceuticals, were among the tested products. According to a Psychologies representative, "Packaging shape, logos and branding were completely obscure to provide a uniquely unbiased platform for reader responses."

Med Spas signed a worldwide agreement with Zymetech from Reykjavick, Iceland,, for the use of Penzim as the essential ingredient in the anti-aging line of products for Natural Renu.

Zymetech owns the worldwide patents for an active ingredient called Penzim derived from enzymes produced by fish, particularly cod in the North Atlantic. This enzyme has been clinically tested for the treatment of pain, inflammation, arthritis, bursitis, eczema, psoriasis, fybromyalgia, eczema, acne and other skin conditions, such as itching, dry skin and brown spots.

About Natural Renu

The company has established a new division to penetrate the $5.4 billion cosmeceutical industry under the brand name Natural Renu. The company's new initiative is a line of cosmeceutical products focusing on the anti aging and skin healthcare markets. The company sales efforts are focused primarily through two marketing channels. The first and primary sales channel is Internet Retailing. The second target audience is to exclusive Plastic Surgeons and Dermatology practices, Day spas, Resorts and Medspas around the world.

SAFE HARBOR STATEMENT: Except for historical information contained herein, the statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results in the future to differ materially from forecasted results. These risks and uncertainties include, among other things, product price volatility, product demand, market competition and risk inherent in the operations of a company.

Contact Information

  • Investor Contact Information:

    Paul Smith
    Investor Relations